Even though therapy with NSAIDs promotes ACE-2 expression, theoretically providing more docking site for SARS-CoV-2, ACE-2 upregulation might also limit the severity of COVID-19 according to the mechanistic background depicted in the introduction [82,83,84]. This evidence concerns the gene ACE2 and COVID-19.